The Effects of Once-Weekly Dulaglutide and Insulin Glargine on Glucose Fluctuation in Poorly Oral-Antidiabetic Controlled Patients with Type 2 Diabetes Mellitus

Table 5

Microvascular complications and other treatments.

Variable	Baseline				Week 52
	Dulaglutide ()	Glargine ()		Dulaglutide ()	Glargine ()
Diabetic nephropathy, (%)	3	2		0.835	3		3	0.412
Other comorbidities, (%)
Hyperlipidemia	5	4	0.509	6	4	0.734
Hypertension	11	5	0.509	11	5	0.509
Other treatments, (%)
CCB	4	3	0.656	4	3	0.656
ACEI/ARB	5	2	0.629	5	2	0.629
Beta-blockers	2	0	0.260	2	0	0.260
Statins	3	2	0.835	4	2	0.876

CCB: calcium channel blockers; ACEI/ARB: angiotensin-converting enzyme inhibitor and/or angiotensin II receptor blocker.